Jennifer Doudna
Founder & Chair of the IGI Governance Board, Innovative Genomics Institute
5th International Conference on CRISPR Technologies
October 31, 2022 to November 2, 2022
CRISPR 2022 brings together investigators focused on enzymes and technologies, predominantly CRISPR-based systems, but also other promising systems and approaches, to discuss advances in the field and ways to harness genome engineering for beneficial purposes. Topics range from fundamental biology to translational and applied applications and include studies across the diversity of life. Importantly, speakers and participants represent both academic and commercial interests.
Sponsors
Our speaker lineup spans a really exciting cross-section of CRISPR biology and applied technology. I am particularly looking forward to sessions on biomedical applications, DNA repair, and genome screening.
Featured Speakers
-
-
Rodolphe Barrangou
Professor, North Carolina State University -
Alberto Ciccia
Associate Professor, Columbia University Medical Center -
Laralynne Przybyla
Head of Biology, Laboratory of Genomics Research at UCSF -
Molly Ohainle
Assistant Professor, UC Berkeley -
Giulia Palermo
Assistant Professor, UC Riverside -
Lacra Bintu
Assistant Professor, Stanford University -
Alejandro Chavez
Assistant Professor, Columbia University -
Henriette O’Geen
Project Scientist, University of California, Davis -
Peter Turnbaugh
Professor, Microbiology And Immunology, UCSF -
Chun-Jun Guo
Assistant Professor , Weill Cornell Medicine -
Kevin Neil
CTO & Co-Founder, TATUM Bioscience -
Dipali Sashital
Associate Professor, Iowa State University -
Yan Zhang
Assistant Professor, University of Michigan -
Gozde Demirer
Assistant Professor of Chemical Engineering , Caltech -
Carlotta Ronda
Associate Research Scientist, Columbia University -
Fyodor Urnov
Professor, UC Berkeley -
Lucas Harrington
Cofounder, Mammoth Biosciences -
Kyle Watters
Principal Scientist, Arbor Biotechnologies -
Asma Hatoum-Aslan
Assistant Professor of Microbiology, University of Illinois at Urbana-Champaign -
David Taylor
Assistant Professor, University of Texas at Austin -
Thomas Gaj
Assistant Professor, University of Illinois -
Vivek Mutalik
Staff Scientist/Principal Investigator, Lawrence Berkeley National Laboratory -
Paula Rio
Head of the Bone Marrow Aplasias Unit, CIEMAT Madrid -
Anna Kajaste-Rudnitski
Group Leader, San Raffaele-Telethon Institute for Gene Therapy -
Elizabeth Kellogg
Assistant Professor, Cornell University -
Peter Fineran
Professor, University of Otago -
Ailong Ke
Professor of Biochemistry and Structural Biology, Cornell University -
Mitchell O'Connell
Assistant Professor of Biochemistry and Biophysics, University of Rochester -
Ilya Finkelstein
Associate Professor, University of Texas at Austin -
Nicole Marino
Post-Doc, University of Southern California -
Gerald Schwank
Assistant Professor, ETH Zurich -
Brady Cress
Principal Investigator: Microbiome Editing Technologies, Innovative Genomics Institute -
Ben Adler
Postdoctoral Researcher, University of California, Berkeley -
Yiping Qi
Associate Professor, Department of Plant Science & Landscape Architecture, University of Maryland -
Katie Geiger-Schuller
Senior Scientist, Genentech -
Kristin Knouse
Assistant Professor of Biology, Massachusetts Institute of Technology -
Sadik Kassim
Chief Technology Officer, Danaher -
Paul Diehl
Chief Operating Officer, Cellecta -
Mark Behlke
Chief Scientific Officer, IDT -
Tom Foti
President of Protein Business Unit, Aldevron -
Zulfiquer Hossain
Technical Application Scientist, MilliporeSigma -
Will DeLoache
Co-Founder and Chief Scientific Officer, Novome Biotechnologies -
Paul Knoepfler
Professor, UC Davis -
Gurumurthy Channabasavaiah
Professor, College of Medicine -
Piyush Jain
Assistant Professor, University of Florida -
Daniela Goltsman
Associate Director of In Silico Biology, Metagenomi
Our keynote and invited speakers are at the forefront of the field. I can barely wait to hear about the latest developments in CRISPR-based precision genome editing approaches for biotechnological, agricultural, and biomedical applications.
Session Topics
Keynote Speaker Rodolphe Barrangou on 10 Years of CRISPR Engineering
Rodolphe Barrangou, Ph.D., the T. R. Klaenhammer Distinguished Professor at North Carolina State University and a keynote speaker, discusses the evolution of CRISPR research, his vision for the future, and what to expect at this year’s conference.
Top Reasons to Attend
- Obtain a broad view of the recent applications and developments in CRISPR technologies, and gain insight into where trends in the field are heading
- Benefit from creative input from colleagues working in allied fields
- Develop new collaborations and build relationships for current and future projects
- Enjoy a slate of exceptional guest speakers presenting the state-of-the-art in CRISPR technologies and beyond
Who Should Attend
- Scientists at all career stages
- Cell biologists in academia and industry at all levels
- Scientists in industry and academia
- Students and senior researchers
- Industry decision makers/tech scouts looking to speed up research and foster new applications